Innovative Approaches in the Management of Sinonasal Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (1 October 2023) | Viewed by 131
Special Issue Editor
Interests: cancer biology; olfactory neuroblastoma; organoids; sinonasal malignancies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Malignancies known as sinonasal cancers develop in the sinonasal area, which includes the paranasal sinuses and nasal cavity. Even though they comprise only 2% of all head and neck cancers, these malignancies can be difficult to treat and frequently necessitate a multidisciplinary approach. Recently, many improvements have been made in the treatment of sinonasal malignancies, especially in the development of novel strategies.
The introduction of minimally invasive surgical methods, such as endoscopic surgery, has been one of the most important developments. Moreover, more accurate and precise staging of sinonasal malignancies is now possible thanks to recent developments in diagnostic imaging, including computed tomography (CT) scans and magnetic resonance imaging (MRI). This has allowed for more individualized treatment plans and better outcomes for patients, such as chemotherapy, radiation therapy, and surgical methods, to enhance patient outcomes while reducing adverse effects. Furthermore, induction chemotherapy and immunotherapy strategies are being actively investigated for many sinonasal tumor types.
Exploring these developments and thoroughly discussing the most effective methods now being used to treat these tumors are the main goals of this Special Issue on innovative approaches in the management of sinonasal tumours. In order to encourage continued development in this area, the Special Issue welcomes original research articles and reviews.
Dr. Nyall London
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- sinonasal malignancies
- minimally invasive surgical methods
- novel treatment startegies
- chemotherapy
- immunotherapy
